U.S.-LISTED SHARES OF BIONTECH UP 17%, NOVAVAX RISE 4.5% AFTER MODERNA AND MERCK'S SKIN CANCER VACCINE SUCCEEDS IN LATE-STAGE TRIAL

Reuters · 1d ago

Please log in to view news